Invention Grant
- Patent Title: Non-cross-reactive anti IgG antibodies
-
Application No.: US13502687Application Date: 2010-10-18
-
Publication No.: US09957331B2Publication Date: 2018-05-01
- Inventor: Ulrich Essig , Stefan Klostermann , Frank Kowalewsky , Kay-Gunnar Stubenrauch , Rudolf Vogel , Uwe Wessels
- Applicant: Ulrich Essig , Stefan Klostermann , Frank Kowalewsky , Kay-Gunnar Stubenrauch , Rudolf Vogel , Uwe Wessels
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agent Grant Kalinowski
- Priority: EP09013144 20091019
- International Application: PCT/EP2010/065617 WO 20101018
- International Announcement: WO2011/048043 WO 20110428
- Main IPC: C07K16/42
- IPC: C07K16/42 ; G01N33/68

Abstract:
Herein are reported the cell lines DSM ACC3006, DSM ACC3007, and DSM ACC3008, as well as the antibodies obtained from the cell lines and the use of an antibody obtained from the cell lines in an immunoassay. Also are reported antibodies binding to human or chimpanzee IgG and not binding to canine and marmoset IgG and antibodies specifically binding to an IgG 1 that comprises a kappa light chain constant domain.
Public/Granted literature
- US20120208216A1 NON-CROSS-REACTIVE ANTI IGG ANTIBODIES Public/Granted day:2012-08-16
Information query